Financials

  • Market Capitalization 20.26 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.17
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
4606
TVGN
Tevogen Bio Holdings Inc. - Common Stock
5.17 USD+3.40%-12.52%-50.38%+310.32%21.65 M USD
4611
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.32 USD-3.33%+0.87%-7.57%+146.81%19.98 M USD
4629
LGVN
Longeveron Inc. - Class A Common stock
0.64 USD+1.59%-3.03%-21.95%+12.03%19.93 M USD
4633
LPCN
Lipocine Inc. - Common Stock
2.30 USD-2.13%-2.13%+1.77%-20.69%18.96 M USD

新闻